In light of the rapidly changing coronavirus (COVID-19) situation, Troutman Sanders and Pepper Hamilton have postponed the effective date of their previously announced merger until July 1, 2020. The new firm – Troutman Pepper – will feature 1,100+ attorneys across 23 U.S. offices. Read more.
Pepper Hamilton LLP represented CR Group, a premier health care investment firm with $4 billion of assets under management, in connection with a definitive merger agreement between TearLab Corporation, a leader in ocular surface diagnostics, and Accelmed Partners II (AP-II) in which AP-II will acquire TearLab. CR Group is TearLab’s senior secured lender.
AP-II will invest $25 million over two tranches that will occur in conjunction with the company delisting from the “over the counter” OTCQB market. After the transaction, TearLab will be a private company and AP-II will be the controlling shareholder. In addition, TearLab and CR Group have agreed to restructure the terms of TearLab’s outstanding senior secured indebtedness.
CR Group was represented by Matthew M. Greenberg, partner and chair of Pepper’s Corporate and Securities Practice Group, and Taylor B. Bartholomew, an associate in the Corporate and Securities Practice Group.